Puberty blockers will be given to more than 200 young people, potentially as young as eight, who think they may be transgender.
Wes Streeting, the Health Secretary, banned the drugs last year because of “unacceptable safety risks”, but they can still be administered as part of clinical trials for patients who meet certain criteria.
For the NHS trial, being run by King’s College London (KCL), children who show a “persisting desire” for the drugs and are deemed by gender doctors as standing a “reasonable prospect of benefit” could be eligible.
Children will be screened for neurodevelopmental conditions such as autism, but participants who are deemed to have such conditions will not be excluded from the trial.
While researchers running the trial acknowledged that children faced potential harm in their cognitive and sexual development, they claimed the risks of not prescribing the drugs could include depression and self-harm.
Article continues at https://www.telegraph.co.uk/news/2025/11/22/nhs-trans-drug-trial-betrays-our-children/ and at https://archive.is/cyLf9